Open-SESAME · OPENing biological barriers using Shell-Engineered Shape-Adaptable Microbubble Enhancers

OPEN-SESAME will assess the technical and commercial feasibility of a modular microbubble platform technology to enhance the delivery of drugs across biological barriers. The project aims to: (i) establish a robust and scalable synthesis protocol for producing shell- and shape-optimized polymeric microbubbles; (ii) evaluate the preclinical performance of our ultrasound-responsive microbubble enhancers in brain and tumor mouse models; (iii) strengthen our intellectual property (IP) position through freedom-to-operate investigation and generation of new IP on microbubble functionalization; (iv) consult key opinion leaders and perform market analysis of the drug therapy enhancer landscape; and (v) consolidate results in an investor-ready business plan to guide the commercialization of our microbubble platform. We anticipate that by exploiting the technological and socio-economic potential identified in the OPEN-SESAME project, we will create completely new opportunities for the use of microbubbles plus ultrasound to enhance drug delivery and improve therapy outcomes in patients suffering from high-medical-need diseases.